Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options

The Oncologist
L GayJeffrey S Ross

Abstract

Esthesioneuroblastoma (ENB), also known as olfactory neuroblastoma, is a rare malignant neoplasm of the olfactory mucosa. Despite surgical resection combined with radiotherapy and adjuvant chemotherapy, ENB often relapses with rapid progression. Current multimodality, nontargeted therapy for relapsed ENB is of limited clinical benefit. We queried whether comprehensive genomic profiling (CGP) of relapsed or refractory ENB can uncover genomic alterations (GA) that could identify potential targeted therapies for these patients. CGP was performed on formalin-fixed, paraffin-embedded sections from 41 consecutive clinical cases of ENBs using a hybrid-capture, adaptor ligation based next-generation sequencing assay to a mean coverage depth of 593X. The results were analyzed for base substitutions, insertions and deletions, select rearrangements, and copy number changes (amplifications and homozygous deletions). Clinically relevant GA (CRGA) were defined as GA linked to drugs on the market or under evaluation in clinical trials. A total of 28 ENBs harbored GA, with a mean of 1.5 GA per sample. Approximately half of the ENBs (21, 51%) featured at least one CRGA, with an average of 1 CRGA per sample. The most commonly altered gene was TP...Continue Reading

References

Nov 1, 1991·Cancer Genetics and Cytogenetics·D R VanDevanterF Luthardt
Aug 8, 2002·Cancer Genetics and Cytogenetics·Seyed H RiazimandWolf J Mann
Jun 15, 2004·Brain Pathology·Ulrike BockmühlIver Petersen
Feb 27, 2007·Cancer Genetics and Cytogenetics·Heidrun HollandPeter Ahnert
Apr 15, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mohamed GuledEdward B Stelow
Aug 25, 2009·Advances in Anatomic Pathology·Hala Faragalla, Ilan Weinreb
Oct 19, 2010·Nucleic Acids Research·Simon A ForbesP Andrew Futreal
Sep 14, 2011·Cancer Chemotherapy and Pharmacology·Matthew G FuryDavid Pfister
Jan 27, 2012·Current Opinion in Otolaryngology & Head and Neck Surgery·Ziv Gil, Dan M Fliss
Feb 17, 2015·Journal of Neurological Surgery. Part B, Skull Base·Bobby A TajudeenMarilene B Wang
Aug 10, 2015·Cancer Treatment Reviews·Paolo BossiAlfio Ferlito
Sep 19, 2015·World Journal of Clinical Cases·Ritesh Kumar
Nov 18, 2015·Current Opinion in Otolaryngology & Head and Neck Surgery·Joseph S SchwartzNithin D Adappa

❮ Previous
Next ❯

Citations

May 15, 2018·Head & Neck·John P MarinelliAshish V Chintakuntlawar
Jun 13, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Snjezana DoganMatija Snuderl
Dec 27, 2019·The American Journal of Surgical Pathology·Cristina RiobelloMario A Hermsen
Aug 19, 2020·BMC Medical Genetics·Sarah K Macklin-MantiaDouglas L Riegert-Johnson
Jun 20, 2020·International Forum of Allergy & Rhinology·Jacob FriedmanPete S Batra
May 8, 2018·Acta Neuropathologica·David CapperUlrich Schüller
Jul 30, 2020·Current Oncology Reports·Matt LechnerValerie J Lund
Aug 18, 2021·Laryngoscope Investigative Otolaryngology·Raman Preet KaurNyall R London
Sep 9, 2020·Bulletin du cancer·Benoit DumontDaniel Orbach
Dec 28, 2021·Current Opinion in Otolaryngology & Head and Neck Surgery·Diana C LopezNyall R London

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.